Pulse Explorar nav.journalClub Debates Tendencias Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

Thomas Chittenden | Synapse

TC

Thomas Chittenden

HER2/EGFR in Cancer Research

NKT Therapeutics (United States)

About

Research focus

HER2/EGFR in Cancer Research

Impact

63 pubs · 5,873 cites · h-index 15

Affiliations

Work Experience

NKT Therapeutics (United States)

2024 - 2024

ImmunoGen (United States)

2001 - 2022

Sanofi (France)

2006 - 2007

Stanford University

1999 - 2001

Brigham and Women's Hospital

1999 - 1999

Publications